| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.18B | $1.09B | $1.04B |
| YoY Revenue Growth % | +8.0% | +5.0% | — |
| Gross Profit | $932.6M | $862.0M | — |
| Gross Margin % | 79.2% | 79.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $83.2M | $79.6M | $50.8M |
| Operating Margin % | 7.1% | 7.3% | 4.9% |
| Net Income (GAAP) | $115.4M | $244.6M | $129.0M |
| EBITDA (Normalized) | $88.0M | $81.7M | $88.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $356.4M | $332.3M | $318.7M |
| Capital Expenditures (CapEx) | $6.1M | $2.6M | $46.7M |
| Free Cash Flow (FCF) | $350.4M | $329.7M | $272.0M |
| FCF Margin % | 29.8% | 30.2% | 26.2% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | 2.0% |
| Cash & Short-Term Equivalents | $375.1M | $624.6M | — |
| Total Debt (Short + Long Term) | $451.0M | $448.6M | $765.3M |
| Total Stockholders' Equity | -$299.3M | -$297.0M | $1.57B |